79 results
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
the meaning ascribed to such term in Section 3.2(j).
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation … , an informal investigation or partial proceeding, such as a deposition), whether pending or, to the Company’s knowledge, threatened against
8-K
EX-10.2
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning … investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance
S-8
EX-5.1
DMAC
DiaMedica Therapeutics Inc.
24 May 24
Registration of securities for employees
4:01pm
and are a complete record of the minutes and resolutions of the directors and shareholders of the Corporation.
We have made no independent investigation
8-K
EX-10.2
firo2aja4rsf
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
r6sb kzza9h1q6g
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
EX-10.2
g9vz eskrgwr9
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
S-8
EX-5.1
4aytm
11 Aug 22
Registration of securities for employees
4:39pm
8-K
EX-99.1
r2fv hjkvng
10 Aug 22
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
5:22pm
8-K
EX-10.1
qke9e9b
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
akhdy 24p
25 May 22
Departure of Directors or Certain Officers
4:49pm
8-K
EX-99.1
cl4 0rpwib
4 May 22
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
4:41pm
S-8
EX-5.1
alyl5x0tbkq bjdi
14 Mar 22
Registration of securities for employees
5:18pm
424B3
04bviszk 6dh4mxw
15 Oct 21
Prospectus supplement
6:32am